4//SEC Filing
Zannes Maria 4
Accession 0001493152-24-015791
CIK 0001712762other
Filed
Apr 23, 8:00 PM ET
Accepted
Apr 24, 4:00 PM ET
Size
8.6 KB
Accession
0001493152-24-015791
Insider Transaction Report
Form 4
Zannes Maria
DirectorPresident & CEO
Transactions
- Exercise/Conversion
Common Stock
2024-04-08$1.16/sh+64,848$75,224→ 229,506 total - Tax Payment
Common Stock
2024-04-08$2.65/sh−28,264$74,900→ 201,242 total - Exercise/Conversion
Stock Option (right to buy)
2024-04-08−64,848→ 0 totalExercise: $1.16Exp: 2024-04-28→ Common Stock (64,848 underlying)
Footnotes (2)
- [F1]Represents shares withheld to cover the exercise price of the options exercised.
- [F2]This option vested in 7 equal monthly installments beginning on April 28, 2014.
Documents
Issuer
bioAffinity Technologies, Inc.
CIK 0001712762
Entity typeother
Related Parties
1- filerCIK 0001481928
Filing Metadata
- Form type
- 4
- Filed
- Apr 23, 8:00 PM ET
- Accepted
- Apr 24, 4:00 PM ET
- Size
- 8.6 KB